Safety Statements (Europe): 16-26-36/37
Signal Word: Danger
Hazard statements: H225-H300 +H310 + H330-H315-H319-H335
Precautionary statements: P210-P260-P264-P280-P284-P301 + P310
Components: ProteoMass™ Bradykinin Fragment 1-7 MALDI-MS Standard, vial of 10 nmol, monoisotopic mol wt 756.3997 Da 1×10 nmol; ProteoMass™ ACTH Fragment 18-39 MALDI-MS Standard, vial of 10 nmol, monoisotopic mol wt 2,464.1989 Da 1×10 nmol; ProteoMass™ P14R MALDI-MS Standard, vial of 10 nmol 1×10 nmol; ProteoMass™ Insulin chain B oxidized MALDI-MS Standard, vial of 10 nmol 1×10 nmol; ProteoMass™ Insulin MALDI-MS Standard, vial of 10 nmol, monoisotopic mol wt 5,729.6087 Da 1×10 nmol; ProteoMass™ Cytochrome c MALDI-MS Standard, vial of 10 nmol, (M+H+) 12,361.96 Da by calculation 1×10 nmol; ProteoMass™ Apomyoglobin MALDI-MS Standard, vial of 10 nmol, (M+H+) 16,952.27 Da by calculation 1×10 nmol; ProteoMass™ Albumin MALDI-MS Standard, vial of 10 nmol, average mol wt 66,429.09 Da by calculation 1×10 nmol; ProteoMass™ Aldolase MALDI-MS Standard, vial of 10 nmol, average mol wt 39,211.28 Da by calculation 1×10 nmol; ProteoMass™ Angiotensin II MALDI-MS Standard, vial of 10 nmol 1×10 nmol; α-Cyano-4-hydroxycinnamic acid, suitable for MALDI-TOF MS 4×10 mg; Sinapinic acid, Use tested for MALDI-TOF Mass Spec. 4×10 mg; Trifluoroacetic acid solution, 0.1% 30 mL; Acetonitrile 30 mL; Trifluoroacetic acid solution-á1% 4 mL